Resmed Inc. buy UBS Group AG
Start price
22.05.23
/
50%
€210.60
Target price
22.05.24
-
Performance (%)
-3.75%
End price
23.05.24
€202.70
Summary
This prediction ended on 23.05.24 with a price of €202.70. With a performance of -3.75%, the BUY prediction by UBS_Group_AG finished with a loss. UBS_Group_AG has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.78 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -0.731% | -0.731% | 6.406% |
| iShares Core DAX® | 0.378% | -1.910% | 22.598% |
| iShares Nasdaq 100 | -0.117% | 3.610% | 16.621% |
| iShares Nikkei 225® | -0.806% | 4.615% | 6.119% |
| iShares S&P 500 | 0.059% | 2.263% | 11.549% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten